Positively and negatively charged ionic modifications to cellulose assessed as cotton-based protease-lowering and hemostatic wound agents

Cellulose

Volumn 16, Issue 5, 2009, Pages 911-921

  Edwards, J Vince ^a   Howley, Phyllis ^a   Prevost, Nicolette ^a   Condon, Brian ^a   Arnold, Judy ^b   Diegelmann, Robert ^c  

^a SOUTHERN REGIONAL RESEARCH CENTER   (United States)

^b RUSSELL RESEARCH CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic wounds; Collagenase; Hemostatic wound agents; Human neutrophil elastase; Ionically modified cotton; Protease lowering

Indexed keywords

CHRONIC WOUNDS; COLLAGENASE; HEMOSTATIC WOUND AGENTS; HUMAN NEUTROPHIL ELASTASE; IONICALLY MODIFIED COTTON; PROTEASE-LOWERING;

ACIDS; AMINO ACIDS; BEARINGS (STRUCTURAL); BLOOD; BLOOD SUBSTITUTES; BUTANE; CELLULOSE DERIVATIVES; CHITIN; CHITOSAN; COTTON; COTTON FIBERS; ETHERS; GRAFTING (CHEMICAL); ION EXCHANGE; LIQUEFIED PETROLEUM GAS; PHOSPHORYLATION; PLATELETS; SURFACE PROPERTIES; UREA;

CELLULOSE;

ACIDS; AGENTS; AMINO ACIDS; BLOOD; BUTANES; CELLULOSE; CELLULOSE DERIVATIVES; CHITIN; CHITOSAN; COTTON; ETHERS; ION EXCHANGE; PHOSPHORYLATION; SURFACE PROPERTIES; UREA;

COTTON FIBER; DRESSING; GRAFTING; MEDICAL TEXTILE; MEDICAL USE; POLYCARBOXYLIC ACID; PROTEASE; SURFACE PROPERTY;

EID: 70349139692     PISSN: 09690239     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10570-009-9302-4     Document Type: Article

References (49)

1. Backdahl H, Helenlus G, Bodin A, Nannmark U, Johansson BR, Risber B, Gatenholm P (2006) Mechanical properties of bacterial cellulose and interactions with smooth muscle cells. Biomaterials 27(9):2141-2149. doi: 10.1016/j.biomaterials.2005.10.026
2. Bank U, Kruger S, Langner J, Roessner A (2000) Review: Peptidases and peptidase inhibitors in the pathogenesis of diseases: Disturbances in the ubiquitin-mediated proteolytic system. Protease-antiprotease imbalance in inflammatory reactions. Role of cathepsins in tumour progression. Adv Exp Med Biol 477:349-378. doi: 10.1007/0-306-46826-3_38
3. Clark RAF (1996) Wound repair: Overview and general considerations. In: Richard AFC (ed) The molecular and cellular biology of wound repair. Plenum Press, New York, pp 3-35
4. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L (2002) Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Reg Rep 10:16-25. doi: 10.1046/ j.1524-475X.2002.10703.x
5. Diegelmann RF (2003) Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen 11:490-495. doi: 10.1046/ j.1524-475X.2003.11617.x
6. Diegelmann RF, Evans MC (2004) Wound healing: An overview of acute, fibrotic and delayed healing. Front Biosci 9:283-289. doi: 10.2741/1184
7. Edwards JV (2006) Future structure and properties of mechanism-based wound dressings. In: Edwards JV, Buschle-Diller G, Goheen SC (eds) Modified fibers with medical and specialty applications. Springer, The Netherlands, pp 11-33
8. Edwards JV, Goheen SC (2006) Performance of bioactive molecules on cotton and other textiles. Res J Text Appar 10(4):19-32
9. Edwards JV, Howley PS (2007) Human neutrophil elastase and collagenase sequestration with phosphorylated cotton wound dressings. J Biomed Mater Res 83A:446-454. doi: 10.1002/jbm.a.31171
10. Edwards JV, Bopp AF, Batiste S, Ullah AJ, Cohen KI, Diegelmann RF, Montante SJ (1999a) Inhibition of elastase by a synthetic cotton-bound serine protease inhibitor: In vitro kinetics and inhibitor release. Wound Repair Regen 7(2):106-118. doi: 10.1046/j.1524-475X.1999.00106.x
11. 2- and COOH-terminal elastase recognition sequences on cotton. J Pept Res 54:543-546. doi: 10.1034/j.1399-3011.1999.00134.x
12. Edwards JV, Yager DR, Cohen IK, Diegelmann RF, Montante S, Bertoniere N, Bopp AF (2001) Modified cotton gauze dressings that selectively absorb neutrophil elastase activity in solution. Wound Rep Reg 9:50-58. doi: 10.1046/j.1524-475x.2001.00050.x
13. Edwards JV, Eggleston G, Yager DR, Cohen IK, Diegelmann RF, Bop AF (2002) Design, preparation and assessment of citrate-linked monosaccharide cellulose conjugates with elastase-lowering activity. Carbohydr Polym 50(3):305-314. doi: 10.1016/S0144-8617(02)00029-2
14. Edwards JV, Bopp AF, Batiste SL, Goynes WR (2003) Human neutrophil elastase inhibition with a novel cotton alginate wound dressing formulation. J Biomed Mater Res Part A 66A(3):433-440. doi: 10.1002/ jbm.a.10517
15. Edwards JV, Howley P, Davis R, Mashchak A, Goheen SC (2007) Protease inhibition by oleic acid transfer from chronic wound dressing to albumin. Int J Pharm 340(1-2):42-51
16. Edwards JV, Parikh DV, Howley P, Batiste S, Condon B (2008) Improving on army field gauze for lethal vascular injuries: Challenges in dressing development, Proceedings of the beltwide cotton conferences, utilization: Nonwoven Symposium, Nashville, 8-11 January, pp 1859-1862
17. Ekerot L, Ohlsson K (1984) Interactions of granulocyte proteases with inhibitors in rheumatoid arthritis. Adv Exp Med Biol 167:335-344
18. Falanga V (1988) Occlusive wound dressings. Why, when, which? Arch Dermatol 124(6):872-877. doi: 10.1001/archderm.124.6.872
19. Favuzza J, Hechman HB (2004) Hemostasis in the absence of clotting factors. J Trauma 57:S42-S44. doi: 10.1097/01.TA.0000136745.89568.D9
20. Grinell F, Zhu M (1994) Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Invest Dermatol 103:155-161. doi: 10.1111/ 1523-1747.ep12392625
21. Guillaume C, Senet P, Vaneau M, Martel P, Guillqume J-C, Meaume S, Teot L, Debure D, Dompmartin A, Bachelet H, Carsin G, Matz V, Richard JL, Rochet MJ, Sales-Aussias N, Zaganoli A, Denis C, Guillot B, Chosidow O (2007) Dressings for acute and chronic wounds. Arch Dermatol 143(10):1297. doi: 10.1001/archderm.143.10.1297
22. Gustafson SB, Fulkerson P, Bildfell R, Aguilera L, Hazzard TM (2007) Chitsosan dressing provides hemostasis in swine femoral arterial injury model. Prehosp Emerg Care 11(2):172-178. doi: 10.1080/10903120701205893
23. Hashimoto T, Suzuki Y, Tanihara M, Kakimaru Y, Suzuki K (2004) Development of aglinate wound dressings linked with hybrid peptides derived from laminin and elastin. Biomaterials 25:1407-1414. doi: 10.1016/j.biomaterials.2003.07.004
24. Hilton JR, William DT, Beuker B, Miller DR, Harding KG (2004) Wound dressings in diabetic foot disease. Clin Infect Dis 39(2):S100-S103. doi: 10.1086/383270
25. Holcomb JB, Mcmullin NR, Pearse L, Caruso J, Wade CE, Oetjen-Gerdes L, Champion HR, Lawnick M, Rodriguez S, Butler FK (2008) Causes of death in US special operations forces in the global was on terrorism: 2001-2004. Ann Surg 245(6):986-991. doi: 10.1097/01.sla.0000259433.03754.98
26. Jaffray C, Yang J, Carter G, Mendez C, Norman J (2000) Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome. Surgery 128(2):225-231. doi: 10.1067/msy.2000.107419
27. Kashyab N, Kumar N, Kumar MNVR (2005) Hydrogels for pharmaceutical and biomedical applications. Crit Rev Ther Drug Carrier Syst 22(2):107-149. doi: 10.1615/CritRevTherDrugCarrierSyst.v22.i2.10
28. Kato Y, Onishi H, Machida Y (2003) Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol 4(5):303-309. doi: 10.2174/1389201033489748
29. Kirker KR, Luo Y, Nielson JH, Shelby J, Prestweich GD (2002) Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials 23(17):3661-3671. doi: 10.1016/ S0142-9612(02)00100-X
30. Meddahi A, Hassan L, Caruelle J-P, Barritault D, Hornebeck W (1996) FGF protection and inhibition of human neutrophil elastase by carboxymethylbenzylamide sulfonate dextran derivatives. Int J Biol Macromol 18:141-145. doi: 10.1016/0141-8130(95)01074-2
31. Meyer-Ingold W, Eichner W, Ettner N, Schink M (2000) Wound coverings for removal of interfering factors from wound fluid. US Patent 6,156,334
32. Miraftab M, Qlao Q, Kennedy JF, Anand SC, Groocock MR (2003) Fibres for wound dressings based on mixed carbohydrate polymer fibres. Carbohydr Polym 53(3):225-231
33. Muroski ME, Roycik MD, Newcomer RG, vanden Steen PE, Opdenakker G, Monroe HR, Sahab ZJ, Sang Q-X (2008) Matrix metalloproteinase-9/ gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr Pharm Biotechnol 9(1):34-46. doi: 10.2174/138920108783497631
34. Pusateri AE, Holcomb JB, Kheirabadi BS, Alam HB, Wade CE, Ryan KL (2006) Making sense of the preclinical literature on advanced hemostatic products. J Trauma 60:674-682. doi: 10.1097/01.ta.0000196672.47783.fd
35. Rayment EA, Dargaville TR, Shooter GK, George GA, Upton Z (2008) Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels. Biomaterials 29(12):1785-1795. doi: 10.1016/j.biomaterials.2007.12.043
36. Remijn JA, Da Costa Martin P, Ijsseldijk MJ, Sixma JJ, de Groot PG, Zwaginga JJ (2006) Impaired platelet adhesion to lysed fibrin whereas neutrophil adhesion remains intact under conditions of flow. Blood Coagul Fibrinolysis 17(5):421-424. doi: 10.1097/ 01.mbc.0000233375.56723.4a
37. Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, Romanelli M, Stacey MC, Teot L, Vanscheidt W (2003) Wound bed preparation: A systematic approach to wound management. Wound Rep Reg 11:1-28. doi: 10.1046/j.1524-475X.11.s2.1.x
38. Shapiro SD (2002) Proteinases in chronic obstructive pulmonary disease. Biochem Soc Trans 30(2):98-102. doi: 10.1042/BST0300098
39. Szczesniak M, Kubis A (1993) The influence of hydrophilizing agents on gel formation rate of cellulose derivatives. Part 3: Effect of hydrophilizing agents and of polymer type on the release rate of hydrocortisone form xerogel dressing. Pharmazie 48(12):926-927
40. Thatte HS, Zagarin SE, Amiji M, Khuri SF (2004) Poly-N-acetyl glucosamine-mediated red blood cell. J Trauma 57(S1):S7-S12
41. Vachon DJ, Yager DR (2006) Novel sulfonated hyrogel composite with the ability to inhibit proteases and bacterial growth. J Biomed Mater Res 76A:35-43. doi: 10.1002/jbm.a.30440
42. Ward KR, Tiba MH, Holbert WH, Blocher CR, Draucker GT, Proffitt EK, Bowlin GL, Ivatury RR, Diegelmann RF (2007) Comparison of a new hemostatic agent to current combat hemostatic agents in a swine model of lethal extremity arterial hemorrhage. J Trauma 63(2):276-284
43. Weckroth M, Vahert A, Lauharanta J, Sorsa T, Konttinen YT (1996) Matrix metalloproteinases, gelatinases and collagenase, in chronic leg ulcers. J Invest Dermatol 106(5):1119-1124. doi: 10.1111/1523-1747.ep12340167
44. Wiegand C, Elsner P, Hipler U-C, Klemm D (2006) Protease and ROS activities influenced by a composite of bacterial cellulose and collagen type I in vitro. Cellulose 13(6):689-696
45. Wiseman DM, Rovee DT, Alvarez OM (1992) Wound dressing: Design and use. In: Cohen IK, Diegelmann RF, Lindbald WJ (eds) Wound healing biochemical & clinical aspects. WB Saunders Co., Philadelphia, pp 562-580
46. Wollina U, Abdel-Naser MB, Verma S (2006) Skin physiology and textiles - consideration of basic interactions. Curr Probl Dermatol 33:1-16. doi: 10.1159/000093926
47. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE (2002) Early healing events in a porcine model of contaminated wounds: Effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Reg Rep 10:141-151. doi: 10.1046/j.1524-475X.2002.10308.x
48. Yager D, Nwomeh B (1999) The proteolytic environment of chronic wounds. Wound Reg Rep 7:433-441. doi: 10.1046/j.1524-475X.1999.00433.x
49. Yager DR, Chen SM, Ward SI, Olutoye OO, Diegelmann RF, Cohen IK (1997) Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Rep Reg 5:23-32. doi: 10.1046/ j.1524-475X.1997.50108.x